Montelukast Prescribing at THE MEADS SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
612
Total Quantity
19.5K
NHS Cost
£959
vs National Avg
-10.6%
THE MEADS SURGERY prescribed 612 items of Montelukast over the last 12 months at a cost of £959 to the NHS. This is 10.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
57
Jul 2026
41
Jul 2026
44
Jul 2026
59
Jul 2026
41
Jul 2026
50
Jul 2026
52
Jul 2026
56
Jul 2026
49
Jul 2026
59
Jul 2026
45
Jul 2026
59
Prescribing Details
| Total Items | 612 |
|---|---|
| Total Quantity | 19,512 |
| Total NHS Cost | £959 |
| Presentations | 4 different forms |
| vs National Average | -10.6% |
Montelukast Prescribing Comparison
| This practice | 612 items |
|---|---|
| National average per practice | 685 items |
| Difference | -10.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.